本页面由Tiger Trade Technology Pte. Ltd.提供服务

Allogene Therapeutics Inc.

2.04
-0.1300-5.99%
盘后2.040.0015+0.07%19:50 EDT
成交量:502.07万
成交额:1,033.33万
市值:7.04亿
市盈率:-3.13
高:2.18
开:2.17
低:2.03
收:2.17
52周最高:4.46
52周最低:1.04
股本:3.45亿
流通股本:2.67亿
量比:0.93
换手率:1.88%
股息:- -
股息率:- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
净资产收益率:-42.39%
总资产收益率:-22.08%
市净率:1.61
市盈率(LYR):-2.36

数据加载中...

2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/08/07

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/22

重要事件披露

Form 8-K - Current report
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/23

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

重要事件披露

Form 8-K - Current report
2026/04/13

重要事件披露

Form 8-K - Current report
2026/04/13

重要事件披露

Form 8-K - Current report
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities